What is Hereditary Cancer?

The genetic software of each individual is formed as a result of the combination of genetic information received from the mother and father. During this assembly, undesirable changes in certain genes are also transferred to the genetic sequence of the baby. As a result of this transfer, hereditary cancers occur in the individual. The fact that only one type of cancer is seen in a family brings to mind the possibility of hereditary cancer in oncology.

If there is more than one family member with the same or a related type of cancer on the mother's or father's side,

  • If there are individuals diagnosed with cancer at an early age in the family,
  • If there is an individual diagnosed with more than one cancer in the family, the presence of hereditary cancer is suspected.
  • Why Are Hereditary Cancer Screening Tests Important?

    The incidence of hereditary cancers passed from mother and/or father to child varies between 5% and 10%. Hereditary Cancer Screening Tests, if applied correctly, play an important role in diagnosing all hereditary cancer types.

    In addition to diagnosing, Hereditary Cancer Screening Tests not only guide the treatment, but also warn at the point of taking medical measures to prevent different types of cancer formations. It helps to provide a more positive treatment process by providing early prevention, diagnosis and diagnosis by creating follow-up awareness not only in the diagnosed individual, but also in other family members.

    What is ONKOGENOKS?

    Onkogenoks makes both a general hereditary cancer table and a specific cancer type-based test by applying both extended and specific gene content related to all hereditary cancers such as breast cancer, ovarian cancer, uterine cancer, stomach cancer on the sample taken from the individual. reveals.

    With Onkogenoks, hereditary cancer screening test reports are prepared by GENOKS Genetic Diseases Evaluation Center, which has Turkey's largest new generation sequencing database.

    GENOKS, which produces genetic data using the leading, most reliable and advanced technology devices all over the world, offers clinical reporting under the guidance of international guidelines.


     Onkogenoks Cancer Panels

    BRCA1 and BRCA2 Hereditary Cancer Screening Panel
    Hereditary Cancer Screening Panel with 140 Genes
    MLPA Analysis for BRCA1 & BRCA2